Target Price | $22.91 |
Price | $6.64 |
Potential |
245.02%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Wave Life Sciences Ltd. 2026 .
The average Wave Life Sciences Ltd. target price is $22.91.
This is
245.02%
register free of charge
$36.00
442.17%
register free of charge
$10.00
50.60%
register free of charge
|
|
A rating was issued by 11 analysts: 10 Analysts recommend Wave Life Sciences Ltd. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2026 of
245.02%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 108.30 | 69.71 |
4.42% | 35.63% | |
EBITDA Margin | -93.94% | -275.44% |
81.06% | 193.20% | |
Net Margin | -98.92% | -225.53% |
35.63% | 128.00% |
11 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2025. The average Wave Life Sciences Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.70 | -1.03 |
29.63% | 47.14% | |
P/E | negative | |
EV/Sales | 10.76 |
5 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. EPS is
This results in the following potential growth metrics and future valuations:
Wave Life Sciences Ltd....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
Jefferies |
Locked
➜
Locked
|
Locked | Feb 25 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Nov 21 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
B. Riley Securities |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 05 2025 |
Locked
Jefferies:
Locked
➜
Locked
|
Feb 25 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Nov 21 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 12 2024 |
Locked
B. Riley Securities:
Locked
➜
Locked
|
Nov 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.